Assisted Reproductive Technology Outcomes After Ethanol Sclerotherapy in Poor Responder Patients with Endometriomas: A Before-After Clinical Trial

Ghasemi, Farah; Kashani, Ladan; Moini, Ashraf; Farid Mojtahedi, Maryam; Shahhosseini, Roza; Alemohammad, Farzaneh

doi:10.18502/jri.v25i3.17017

Assisted Reproductive Technology Outcomes After Ethanol Sclerotherapy in Poor Responder Patients with Endometriomas: A Before-After Clinical Trial

Authors

Farah Ghasemi ¹

Ladan Kashani ¹

Ashraf Moini ²

Maryam Farid Mojtahedi ¹

Roza Shahhosseini ¹

Farzaneh Alemohammad ¹

¹ Department of Obstetrics and Gynecology, Arash Women's Hospital, Tehran University of Medical Sciences, Tehran, Iran

² Department of Obstetrics and Gynecology, Endocrinology and Female Infertility Unit, Arash Women's Hospital, Tehran University of Medical Sciences, Tehran, Iran; Department of Endocrinology and Female Infertility, Reproductive Biom

10.18502/jri.v25i3.17017

Abstract

Background: The purpose of the present study was to investigate the assisted reproductive technology (ART) outcomes after ethanol sclerotherapy (EST) in poor responder patients with endometriomas. Methods: In this before-after clinical trial, the outcomes of ART of 31 poor responders with endometriomas were evaluated after EST between July 2023 to March 2024. These patients had undergone ART at least in one cycle before and did not respond well. Recurrence rate, antral follicle count (AFC), anti-Müllerian hormone (AMH), and relief of symptoms including dysmenorrhea and abnormal uterine bleeding (AUB) were evaluated before the procedure. Follow-up assessments were conducted two and six weeks after the procedure for evaluating the complications. Fisher’s exact test, chi-square test, and paired sample t-test were used for statistical analysis using SPSS 24. Results: In this study, the levels of AFC and AMH increased significantly after endometrioma stripping therapy (p<0.05). Additionally, the number of embryos obtained increased significantly, indicating potential improvement in oocyte quality. There was a significant reduction in pelvic pain scores (p=0.001), as well as a notable decrease in dysmenorrhea (p=0.02) and dyspareunia (p=0.001). Moreover, 16.12% of patients reported recovery from intermenstrual bleeding. However, no significant difference was observed in the amount of gonadotropin used (p=0.56). Conclusion: EST is an appropriate and safe procedure before ART for poor responders who have endometriomas and can be a replacement for surgery among selected patients.

Keywords

ART outcome

Endometrioma

Ethanol sclerotherapy

Jee BC. Efficacy of ablation and sclerotherapy for the management of ovarian Endomerioma:A narrative review. Clin Exp Reprod Med. 2022;49(2):76-86.

Tsolakidis D, Pados G, Vavilis D, Athanatos D, Tsalikis T, Giannakou A, et al. The impact on ovarian reserve after laparoscopic ovarian cystectomy versus three-stage management in patients with endometriomas: a prospective randomized study. Fertil Steril. 2010;94(1):71-7.

Pais AS, Flagothier C, Tebache L, Almeida Santos T, Nisolle M. Impact of surgical management of endometrioma on AMH levels and pregnancy rates: a review of recent literature. J Clin Med. 2021;10(3):414.

Benaglia L, Somigliana E, Vighi V, Ragni G, Vercellini P, Fedele L. Rate of severe ovarian damage following surgery for endometriomas. Hum Reprod. 2010;25(3):678-82.

Gao X, Zhang Y, Xu X, Lu S, Yan L. Effects of ovarian endometrioma aspiration on in vitro fertilization-intracytoplasmic sperm injection and embryo transfer outcomes: a systematic review and meta-analysis. Arch Gynecol Obstet. 2022;306(1):17-28.

Tomassetti C, Adamson D, Arici A, et al. EndoART: a prospective randomized controlled trial on endometriomas in assisted reproductive technologies, comparing the effect of no intervention, surgery, and prolonged GnRH downregulation on pregnancy rates. J Endometr Pelvic Pain Disord. 2018;10(3):158-73.

Soliman M, Sisson B. What is sclerotherapy? What to expect and all else you need to know. Updated December 12, 2021. Available from: [https://www.sciencedirect.com/science/article/pii/S0972978X21001288].

Martinez-Garcia JM, Candas B, Suarez-Salvador E, Gomez M, Merino E, Castellarnau M, et al. Comparing the effects of alcohol sclerotherapy with those of surgery on anti-mullerian hormone and ovarian reserve after endometrioma treatment: a prospective multicenter pilot cohort study. Eur J Obstet Gynecol Reprod Biol. 2021;259:60-6.

Chen Y, Pei H, Chang Y, Chen M, Wang H, Xie H, et al. The impact of endometrioma and laparoscopic cystectomy on ovarian reserve and the exploration of related factors assessed by serum anti-Müllerian hormone: a prospective cohort study. J Ovarian Res. 2014;7:108.

Han MT, Cheng W, Zhu R, Wu HH, Ding J, Zhao NN, et al. The cytokine profiles in follicular fluid and reproductive outcomes in women with endometriosis. Am J Reprod Immunol. 2023;89(6):e13633.

Muñoz-Hernando L, Muñoz-Gonzalez JL, Marqueta-Marques L, Alvarez-Conejo C, Tejerizo-García Á, Lopez-Gonzalez G, et al. Endometriosis: alternative methods of medical treatment. Int J Womens Health. 2015;7:595-603.

Kalaitzopoulos DR, Samartzis N, Daniilidis A, Leeners B, Makieva S, Nirgianakis K, et al. Effects of vitamin D supplementation in endometriosis: a systematic review. Reprod Biol Endocrinol. 2022;20(1):176.

Leibetseder A, Schoeffmann K, Keckstein J, Keckstein S. Endometriosis detection and localization in laparoscopic gynecology. Multimed Tools Appl. 2022;81(5):6191-215.

Chapron C, Vercellini P, Barakat H, Vieira M, Dubuisson JB. Management of ovarian endometriomas. Hum Reprod Update. 2002;8(6):591-7.

Park HJ, Kim H, Lee GH, Yoon TK, Lee WS. Could surgical management improve the IVF outcomes in infertile women with endometrioma? Obstet Gynecol Sci. 2019;62(1):1-10.

García-Tejedor A, Castellarnau M, Ponce J, Eulalia F, Burdio F. Ethanol sclerotherapy of ovarian endometrioma: a safe and effective minimally invasive procedure. Eur J Obstet Gynecol Reprod Biol. 2015;18:25-29.

Kim GH, Kim PH, Shin JH, Nam IC, Chu HH, Ko HK. Ultrasound-guided sclerotherapy for the treatment of ovarian endometrioma: an updated systematic review and meta-analysis. Eur Radiol. 2022;32(3):1726-37.

Dunselman GA, Vermeulen N, Becker C, Calhaz-Jorge C, D’Hooghe T, De Bie B, et al. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014;29:400-12.

Sánchez AM, Vigano P, Somigliana E, Panina-Bordignon P, Vercellini P, Candiani M. The distinguishing cellular and molecular features of the endometriotic ovarian cyst: from pathophysiology to the potential endometrioma-mediated damage to the ovary. Hum Reprod Update. 2014;20:17-30.

Zhu W, Tan Z, Fu Z, Li X, Chen X, Zhou Y. Repeat transvaginal ultrasound-guided aspiration of ovarian endometrioma in infertile women with endometriosis. Am J Obstet Gynecol. 2011;204:61.e1-6.

Alborzi S, Ravanbakhsh R, Parsanezhad ME, Alborzi M, Alborzi S, Dehbashi S. A comparison of follicular response of ovaries to ovulation induction after laparoscopic ovarian cystectomy or fenestration and coagulation versus normal ovaries in patients with endometrioma. Fertil Steril. 2007;88(2):507-9.

Chan LY, So WW, Lao TT. Rapid recurrence of endometrioma after transvaginal ultrasound-guided aspiration. Eur J Obstet Gynecol Reprod Biol. 2003;109(2):196-8.

Donnez J, Nisolle M, Gillerot S, Anaf V, Clerckx-Braun F, Casanas-Roux F. Ovarian endometrial cysts: the role of gonadotropin-releasing hormone agonist and/or drainage. Fertil Steril. 1994;62(1):63-6.

Gonçalves FC, Andres MP, Passman LJ, Gonçalves MO, Podgaec S. A systematic review of ultrasonography-guided transvaginal aspiration of recurrent ovarian endometrioma. Int J Gynaecol Obstet. 2016;134(1):3-7.

Huang L, Chang MY, Shiau CS, Hsieh TT. Changes in anti-Müllerian hormone after ultrasound-guided aspiration and ethanol sclerotherapy of ovarian cyst. Taiwan J Obstet Gynecol. 2021;60(3):509-51.

Garcia-Tejedor A, Martinez-Garcia JM, Candas B, Suarez E, Manalich L, Gomez M, et al. Ethanol sclerotherapy versus laparoscopic surgery for endometrioma treatment: a prospective, multicenter, cohort pilot study. J Minim Invasive Gynecol. 2020;27(5):1133-40.

Suganuma N, Wakahara Y, Ishida D, Asano M, Kitagawa T, Katsumata Y, et al. Pretreatment for ovarian endometrial cyst before in vitro fertilization. Gynecol Obstet Invest. 2002;54 Suppl 1:36-40; discussion 41-2.

Hsieh CL, Shiau CS, Lo LM, Hsieh TT, Chang MY. Effectiveness of ultrasound-guided aspiration and sclerotherapy with 95% ethanol for treatment of recurrent ovarian endometriomas. Fertil Steril. 2009;91(6):2709-13.

Alborzi S, Zahiri Sorouri Z, Askari E, Poordast T, Chamanara K. The success of various endometrioma treatments in infertility: a systematic review and meta-analysis of prospective studies. Reprod Med Biol. 2019;18(4):312-22.

Cohen A, Almong B, Tulandi T. Sclerotherapy in the management of ovarian endometrioma: systematic review and meta-analysis. Fertil Steril. 2017;108(1):117-24.e5.

Alborzi S, Askary E, Keramati P, Alamdarloo SM, Poordast T, Ashraf MA, et al. Assisted reproductive technique outcomes in patients with endometrioma undergoing sclerotherapy vs laparoscopic cystectomy: prospective cross-sectional study. Reprod Med Biol. 2021;20(3):313-20.

Alborzi S, Namavar Jahromi B, Ahmadbeigi M. Recovery rate of patients with recurrent ovarian endometriomas using sclerotherapy with 95% ethanol. J Obstet Gynaecol Cancer Res. 2018;3(3):105-10.

Ikuta A, Tanaka Y, Mizokami T, Tsutsumi A, Sato M, Tanaka M, et al. Management of transvaginal ultrasound-guided absolute ethanol sclerotherapy for ovarian endometriotic cysts. J Med Ultrason (2001). 2006;33(2):99-103.

Yazbeck C, Madelenat P, Ayel JP, Jacquesson L, Bontoux LM, Solal P, et al. Ethanol sclerotherapy: a treatment option for ovarian endometriomas before ovarian stimulation. Reprod Biomed Online. 2009;19(1):121-5.

Noma J, Yoshida N. Efficacy of ethanol sclerotherapy for ovarian endometriomas. Int J Gynaecol Obstet. 2001;72(1):35-9.

Chang MY, Hsieh CL, Shiau CS, Hsieh TT, Chiang RD, Chan CH. Ultrasound-guided aspiration and ethanol sclerotherapy (EST) for treatment of cyst recurrence in patients after previous endometriosis surgery: analysis of influencing factors using a decision tree. J Minim Invasive Gynecol. 2013;20(5):595-603.

Miquel L, Preaubert L, Gnisci A, Resseguier N, Pivano A, Perrin J, et al. Endometrial ethanol sclerotherapy could increase IVF live birth rate in women with moderate-severe endometriosis: retrospective cohort study. PLoS One. 2020;15(9):e0239846.

Tehrani HG, Tavakoli R, Hashemi M, Haghighat S. Ethanol sclerotherapy versus laparoscopic surgery in management of ovarian endometrioma; a randomized clinical trial. Arch Acad Emerg Med. 2022;10(1).

Lee JK, Ahn SH, Kim HI, Lee YJ, Kim S, Han K, et al. Therapeutic efficacy of catheter-directed ethanol sclerotherapy and its impact on ovarian reserve in patients with ovarian endometrioma at risk of decreased ovarian reserve: a preliminary study. J Minim Invasive Gynecol. 2022;29(2):317-23.